Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a newer release of the page or system.
    Difference
    0.0%
    Check dated 2026-07-27T05:56:39.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page build or content.
    Difference
    0.0%
    Check dated 2026-07-05T11:44:36.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, representing a small version update to the page's backend/template without altering visible study information.
    Difference
    0.0%
    Check dated 2026-06-28T08:40:32.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page gains new user-guidance sections and a renamed Intervention/Treatment area, while also showing that recruitment is closed and noting a page revision to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:08:37.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing Revision: v3.5.4. This reflects a site update rather than any change to the study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-06-07T01:39:00.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.5.4 now appears on the page, updating the site version label. The previous label Revision: v3.5.3 has been removed.
    Difference
    0.0%
    Check dated 2026-05-16T10:50:24.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.